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Evolutionary biology within medicine: a perspective
of growing value
Evolutionary biology provides an essential perspective on the determinants of health and disease,
believe Peter Gluckman and Carl Bergstrom. It needs to be further integrated into medical research
and teaching
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In the preface to his 1794 treatise Zoonomia—perhaps the first
book in English to present concepts from which modern
evolutionary thought eventually arose—Erasmus Darwin,
scientist and grandfather of Charles Darwin, wrote that the
purpose of such studies is to elucidate the origins of disease.
Yet evolutionary biology has had little explicit role in the
training of health professionals
1 and thus in how medicine is
practised and research questions are developed.
Over the past decade, however, the explicit application of
evolutionary principles has started to appear within a small but
increasing number of medical schools, reflecting a growing
recognition of the important perspectives offered on the
determinantsofhealthanddiseasebothinindividualsandacross
populations.
2 3 4 5TheAmericanAssociationofMedicalColleges
has recently recommended establishing evolutionary biology
asarequiredpremedicalcompetencyandemphasisedthevalue
ofevolutionaryapproacheswithinthemedicalcurriculumitself.
1
Key developments in evolutionary biology and its insights for
medicineincludetherecognitionthatcontemporaryevolutionary
change is ubiquitous; the accumulation of data on genomic
variation within and between human populations; a growing
understandingofcoevolutionaryrelationshipsbetweenhostand
pathogen; the emergence of major research programmes into
symbioses, particularly in relationship to the gastrointestinal
microbiome; and an understanding of how evolutionary
principles explain the implications of rapidly changing
environmentsfordiseasesusceptibilityandhumanbehaviour.
4 5
A broader understanding of symptoms of illness such as pain
and fever can be developed from an evolutionary perspective
and this has clinical implications, such as when to use
antipyretics.
Howshouldmedicalschoolsandprogrammesforundergraduate,
specialist,andcontinuingmedicaleducationtrainingincorporate
evolutionary biology into medicine?
6
Major themes in evolutionary medicine
Evolutionary science addresses medicine in a manner distinct
from but complementary to other basic sciences, and provides
hypotheses to explain many aspects of human biology and
anatomy.
Some of these hypotheses are adaptive explanations that tell us
about the functional significance of traits. For example, human
infants are the fattest of all mammals at birth and this has
implications for the propensity for humans to develop obesity
and its complications later in life. This trait probably has its
origin in the need to defend the rapidly growing brain against
undernutrition that was likely during weaning.
7 Understanding
this could have direct implications for optimal approaches to
infant nutrition.
Others are phylogenetic explanations that explain the
evolutionaryhistoryoftraits.Ourinabilitytosynthesisevitamin
C, for example, has its origin in our frugivore primate ancestry,
and is exposed as scurvy only when humans encountered
atypical diets such as those on 18thcentury ship voyages.
5 Life
history perspectives have allowed a better understanding of the
significance of the changing age of puberty and provide an
explanation of how developmental factors increase the risk of
disease later in life. Studies of coevolution are essential to
understanding antibiotic resistance and the role of the gut
microbiome.
Importantly, evolutionary principles generally provide
explanations of the origins of individual variation in
vulnerability to disease rather than the cause of disease itself.
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Feature
FEATUREDifferent levels of explanation
The distinction between explanations at the proximate level
(pertainingtodirectphysiologicalandontogeneticcauses),and
explanationsattheultimatelevel(pertainingtotheevolutionary
origins, history, and reasons for the persistence of a trait), has
useful heuristic value.
8 Proximate explanations lay out the
mechanisticchainofdiseasedevelopmentandcausealongwhich
we hope to intervene; their study and application dominates in
medicalresearch,training,andpractice.Ultimateexplanations,
however, interpret how these vulnerabilities came to be in the
first place, which has implications for patient and population
management. Taken together, proximate and ultimate
understandings provide a comprehensive view of a particular
clinical state.
Type two diabetes mellitus, for example, can be understood in
terms of altered insulin release by the pancreatic beta cell and
impaired action via its receptor and signalling cascade
(proximate causation); or as a mismatch between evolved
biology and the evolutionarily novel nutritional and energetic
environments in which most humans now live (ultimate
causation).
9
Both approaches have clear value in explaining the problem to
the patient and both lead to potential therapeutic approaches,
whether pharmacological or lifestyle based. Proximate
explanationsarethebasisofclassificationsofdiseasecausation
generallyusedinpathology(neoplastic,inflammatory,immune,
and so on). Classifications based on ultimate explanations to
explainvulnerabilityhavealsobeendeveloped.
4 5Thedistinction
and synthesis of these two levels of explanation provides an
integrative view of human biology and enhances clinical
practice. Patients often find the ultimate levels of explanation
easy to comprehend and satisfying.
Health, longevity, and fitness
Humanevolutionisbasedonselectionformaximalreproductive
success(whichevolutionarybiologiststermfitness)ratherthan
for health or longevity; this is a fundamental evolutionary
principle yet tends to be poorly appreciated within medicine.
Survival to reproduction and throughout reproductive life will
be the focus of natural selection; survival later in life will be
lessstronglyselectedandthusselectionmayhavecompromised
health in middle and old age.
10 The principle of fitness provides
a partial explanation for the emergence of non-communicable
diseases in middle age and the failure of natural selection to
minimise the risk of such disease.
The concept of trade-offs
Organisms cannot be perfect at everything. Selection typically
drives the evolution of a beneficial trait until the marginal
benefits of continuing are balanced out by the marginal costs
of doing so. So the size of the fetal head is constrained by
mechanisms limiting fetal growth to maternal pelvic size,
contributing to the challenges of human obstetrics, as distinct
from the ease of delivery in other primates. Long human
postnatal dependency is thus explained; we are more immature
at birth than the other great apes because brain development
must be abbreviated in utero for successful delivery.
Lifehistorytrade-offsbetweenearlyinvestmentinreproduction
versus later investment in repair and maintenance are at the
basis of our understanding of the biology of ageing,
10 and
provide explanations for many other aspects of the human
condition. For example, individuals living in uncertain
circumstances are likely to deploy strategies appropriate for a
shorter life span, such as earlier puberty, as evidenced by the
younger age at menarche of girls born into disadvantaged
environments in the developing world and migrating to the
West,
11 and by earlier menarche of girls in Western populations
of lower birth weight. There may be broader public health
implications for such trade-offs, where investment is made for
the present rather than later.
12
Similarargumentshavebeenappliedtoexplaintherelationship
between early life exposures and later risks of disease. Low
birth weight can be seen as an essential trade-off for immediate
survival within a poor intrauterine milieu, but being born small
has the consequences of greater postnatal morbidity and
mortality.
13Moresubtlechangesinmaternalnutritionthatneed
not affect birth size may induce epigenetic changes in the
offspring.
14 Such changes generate a metabolic physiology
appropriate for a low quality nutritional environment, but the
individualisthenplacedatgreaterriskofdevelopingmetabolic
disease in nutritionally rich environments. This may explain
population and individual variations in the sensitivity to
obesogenic environments.
Understanding the dynamics of ongoing
change
The human organism is a complex multi-species assemblage.
Our somatic cells are outnumbered 10 to one by prokaryotic
symbionts, commensals, and pathogens present within our
body.
15 We have only recently started to understand the
significanceofthismicrobialflora.Understandingthathostand
microbe alike have been shaped by ongoing selection allows us
to make sense of how such communities are assembled and
regulatedbyourownphysiologyandexperiences.Forexample,
alterations in gut microbiota are associated with both caesarean
section and lack of exposure to breast milk, and both have been
implicatedintheincreasedprevalenceofallergicdisease
16;these
findings have given rise to the growing study of the use of
probiotics as components of infant formula.
We are now able to comprehend and model medically relevant
contemporary evolutionary changes. Many involve pathogen
evolution, either at the scale of an individual host (such as the
evolution of the human immunodeficiency virus in response to
antiretroviraltherapy)oratthepopulationlevel(suchasannual
evolution of the influenza virus, and the evolution and spread
ofantibioticresistantbacteria).Evolutionarymodelsatthelevel
of a single organism have proved useful in understanding the
progression of neoplasia and the development of resistance to
chemotherapy.
17
Impact of recent rapid environmental change
Given the rapid environmental changes resulting from our
evolved technological capacity and affecting our nutritional,
social, and physical environments, mismatches can occur
between our present environmental exposures and those for
whichourphysiologyhasevolved,asillustratedbytheexample
of metabolic disease.
9 ⇓
The place of evolutionary medicine in
practice and research
Evolutionary thought will only on occasion directly affect
individual therapeutic decisions. Yet it will form a critical part
of the worldview for the practice of medicine. Evolutionary
reasoning provides a conceptual framework within which to
situate the profusion of facts that constitute medicine, and so
helps organise knowledge of biological systems.
4 It allows the
physician to answer patients’ questions about the origin of
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FEATUREsymptoms and disease in a more holistic and often more
meaningful manner. It can be of particular value in
understanding psychiatric symptoms such as phobias, and can
be used as part of their clinical management.
18 Evolutionary
thinkingalsoprovidesanevaluativecontextinwhichtoconsider
individualclinicaldecisionsandthemedicalscientificliterature.
Forexample,whatistheplausibilityandtherapeuticsignificance
of selection arguments used to explain ethnic differences in the
origin of hypertension?
19 What is the appropriate approach to
antibiotic use to minimise the risk of resistance in a hospital?
20
Medicalresearchisintrinsicallyconcernedwithapplicationand
intervention, and it is from the proximate level insights that we
are most likely to be able to develop direct applications.
However, ultimate explanations provide a powerful tool for
generating productive hypotheses about proximate cause.
Recent observations, for example, demonstrate that neural
maturation is not complete until after 25 years of age, and there
isevidencesuggestingthatthedelay,inassociationwithearlier
pubertal maturation, contributes to mental health (and other)
disordersofadolescence.
21Severalalternativehypotheses,each
withdifferentimplications,derivefromanevolutionaryanalysis:
firstly, perhaps late neural maturation has always occurred and
it is the complexity of modern society that exposes the
consequences; secondly, perhaps it takes longer for the brain to
maturebecauselearningthenecessarysocietaltaskstakeslonger
inacomplexsociety;andthirdly,perhapsthepatternofWestern
child rearing has affected the maturation of components such
as the frontothalamic pathways regulating impulse control.
9
Eachofthesehypothesescanbetestedempirically:thefirsttwo
by cross cultural studies of neural maturation and the last by
evaluation in different educational systems. The implications
could be considerable for medicine, psychology, and social
science.Inshort,byaskinghowandwhyfeaturesofourbiology
have evolved, we arrive at a new set of research questions and
a new proximate level research agenda.
Evolutionary approaches have long played a vital role in
prevention,treatment,andmanagementstrategiesinthedomain
of infectious disease. Many aspects of microbial ecology come
togethertocreateasocalledperfectstormforrapidevolutionary
change: pathogens typically have huge population sizes and
short generation times while undergoing strong selection from
the immune system and antimicrobial chemotherapies alike.
We see this in the rapid emergence of multidrug resistance.
Solvingtheproblemwillrequireconsiderationofhowantibiotic
use should be modified to take account of the evolutionary
principles involved.
20 22 The study of the ongoing evolution of
influenza virus strains plays an important role in vaccine
strategies. The same principles may be important in cancer
chemotherapy as well.
A common misperception is that evolutionary biology is an
inherently historical science and thus cannot be subject to
hypothesis testing. From this, it is mistakenly concluded that
evolutionary concepts remain hypothetical and often
teleological. This is wrong on two counts. Firstly, evolutionary
changecanbereadilyobserved,measured,andperturbedinreal
time, particularly in medically relevant systems such as
microbial pathogens.
23 Secondly, as geologists and
astrophysicists know well, historical hypotheses are fully
testable: different past scenarios make different predictions
about present observables, and we can test these predictions by
looking at new data. Nesse has laid out some of the criteria that
are useful in testing evolutionary hypotheses.
24
The future of evolutionary medicine
Evolutionary medicine will not—and should not—emerge as a
distinct clinical discipline. Rather, evolutionary reasoning is a
core competency just as anatomy and communication skills are
corecompetenciesformostphysicians.Evolutionaryreasoning
will only rarely lead to different therapeutic choices, as in the
case of antibiotic management, although it may lead to new
clinical insights. Evolutionary biology provides a worldview
for the physician—an integrated view of human biology, and a
powerful paradigm for generating a broader research agenda.
Evolutionaryexplanationsmayofferthepatientvaluableinsights
into their condition: “Why is this happening to me? Why is my
body letting me down?” Science, through an understanding of
our evolutionary history and the evolutionary processes that
constructed our physiology, will come closest to answering the
question, “What does it mean to be a human organism?”
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FEATUREFigure
Scurvy, cephalopelvic disproportion, and antibiotic resistance: evolutionary biology offers invaluable insights
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